NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: A case-control study

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 5, 2001, Pages 567-568

  Rollinson, S ^a   Roddam, P ^a   Willett, E ^a   Roman, E ^a   Cartwright, R ^a   Jack, A ^a   Morgan, G J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; GENE PRODUCT; PROTEIN NAT2; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ACETYLATOR PHENOTYPE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELISM; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTOXICITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING HABIT;

ADOLESCENT; ADULT; AGED; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING;

EID: 0034926350     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Tobacco and the risk of acute leukaemia in adults
2. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid